Liver transplant for children

Liver transplant for children requires specialized skills. Pediatric liver transplant

Liver transplant for children requires specialized skills.

Start Your Donor Evaluation

Begin the process of becoming a living kidney or liver donor by clicking here to complete a Health History Questionnaire.

At Mayo Clinic's campus in Minnesota, a team of doctors trained in liver conditions (hepatologists), infectious diseases and mental health conditions (psychiatrists) work together to evaluate and treat children who may need liver transplants. Children who need hospitalization receive care in the transplant unit at Mayo Eugenio Litta Children's Hospital.

Why choose Mayo Clinic for my child's liver transplant?

In some ways, the process for liver transplant in children is similar to that for adults. But because children with liver disease face unique challenges, they will benefit from the extensive experience of Mayo Clinic's liver transplant surgeons who have extensive experience in both pediatric and adult liver transplantation.

  • The experts at the pediatric liver clinic and Transplant Center work together to ensure your child gets exactly the care he or she needs.
  • The pediatric liver doctor directs the immunosuppression treatment after your child's liver transplant. These drugs are needed to help prevent your child's body from rejecting the new liver.
  • A multidisciplinary team works with you and your child throughout the transplant process. This team includes the liver transplant surgeon, the pediatric liver doctor, the infectious disease doctor, pharmacists, dietitians, physical therapists, clinical nurse specialists, physician assistants and nurses. It usually includes social workers, child-life specialists, chaplains and transplant financial coordinators as well.
  • When the time is right, your adolescent child will experience a seamless transition to adult hepatologists with expertise in congenital liver disease and post-transplantation care.
  • Doctors of the pediatric liver clinic have special interest in the emerging impact of fatty liver disease in children and in pediatric patients transplanted for liver cancer, including living-related transplant.
  • Doctors at Mayo Clinic have extensive experience with liver and kidney transplant for oxalosis and polycystic kidney disease.

Nationally recognized expertise

Mayo Clinic in Rochester, Minn., ranks No. 1 for digestive disorders in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked among the Best Hospitals for digestive disorders by U.S. News & World Report.

How do I know if my child is eligible for transplant?

The transplant team evaluates your child to determine if a liver transplant is the most appropriate treatment for your child's liver condition. If the team determines your child is eligible for a liver transplant, he or she will be placed on a waiting list for a deceased-donor liver and may also be considered for a living-donor liver transplantation.

Where will the new liver come from?

Your child may be eligible for either a deceased-donor liver transplant or a living-donor liver transplant. In liver transplant for children, surgeons may use an entire deceased-donor liver or a portion of a deceased-donor liver. If a living donor is available, your child's liver is replaced with a portion of an adult living-donor's liver, which then grows to be the size needed by the child.

Learn more about the Mayo Clinic Living-Donor Program.

Who will do the surgery?

Your child's surgery will be performed by a pediatric operating team, led by a liver transplant surgeon with extensive experience in pediatric and adult liver transplantation, as well as an anesthesia team specializing in the care of children.

What can I expect after my child's surgery?

Immediately following the surgery, your child will be cared for in the pediatric intensive care unit by doctors and nurses who specialize in the care of children with very complex medical conditions. How long your child stays in the hospital after surgery depends on his or her medical condition and recovery. The transplant team will monitor your child's recovery.

After your child has left the hospital, you and your child will need to stay near the hospital for about two to four weeks so that doctors can monitor his or her recovery. Your child will have regular follow-up appointments to check for signs of rejection. After the transplant, a liver transplant coordinator who is a registered nurse will provide your child with continuing care, in cooperation with the pediatric liver doctor and the liver transplant surgeon.

The transplant team will work closely with your primary care provider to coordinate care close to home once you have completed your recovery period.

Outcomes following liver transplantation for children are excellent. But children with a new liver will need medicines for the rest of their life to help prevent complications. And they'll need to visit the liver doctor regularly to make sure the new liver is working well and that the dose of medications are adjusted properly as your child grows.

Jan. 17, 2018
  1. Scientific Registry of Transplant Recipients. April 11, 2016.
  2. U.S. News & World Report. U.S. News Best Hospitals 2015-16. Accessed Feb. 22, 2016.
  3. Barbara Woodward Lips Patient Education Center. Liver transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  4. Eggebraaten KR (expert opinion). Mayo Clinic, Rochester, Minn. May 23, 2016.
  5. Barbara DW, et al. The perioperative management of patients undergoing combined heart-liver transplantation. Transplantation. 2015;99:139.
  6. Bulatao IG, et al. Avoiding stay in the intensive care unit after liver transplantation: A score to assign location of care. American Journal of Transplantation. 2014;14:2088.
  7. Heimbach JK (expert opinion). Mayo Clinic, Rochester, Minn. June 28, 2016.
  8. Stulak JM, et al. Combined heart and abdominal organ transplantation: Excellent outcomes gained from a unique experience. Journal of Heart and Lung Transplantation. 2014;33:S278.
  9. Ibrahim SH (expert opinion). Mayo Clinic, Rochester, Minn. June 14, 2016.
  10. Glorioso JM, et al. Pivotal preclinical trial of the spheroid reservoir bioartificial liver. Journal of Hepatology. 2015;63:388.
  11. Heimbach JK, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. American Journal of Transplantation. 2013;13:363.
  12. Murad SD, et al. Long-term clinical and radiological follow up of living liver donors. Liver Transplantation. In press. Accessed May 11, 2016.
  13. Murad SD, et al. Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology. 2012;56:973.
  14. Barbara Woodward Lips Patient Education Center. About your child's liver transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2009.
  15. Rizvi S, et al. Primary sclerosing cholangitis as a premalignant biliary tract disease: Surveillance and management. Clinical Gastroenterology and Hepatology. 2015;13:2152.
  16. Taner T, et al. Decreased chronic cellular and antibody-mediated injury in the kidney following simultaneous liver-kidney transplantation. Kidney International. 2016;89:909.
  17. Watt KD, et al. A practical guide to the management of HCV infection following liver transplantation. American Journal of Transplantation. 2009;9:1707.
  18. Rosen CB, et al. Liver transplantation for cholangiocarcinoma. Transplant International. 2010;23:692.
  19. Raichlin E, et al. Combined heart and liver transplantation: A single-center experience. Transplantation. 2009;88:219.
  20. Nagourney E. 'Domino' transplants: Rare and risky. The New York Times. Accessed May 12, 2016.
  21. Kitchens WH. Domino liver transplantation: Indications, techniques, and outcomes. Transplantation Reviews. 2011;25:167.
  22. Yu Y, et al. Cell therapies for liver diseases. Liver Transplantation. 2012;18:9.
  23. Croome KP, et al. The use of donation after cardiac death allografts does not increase recurrence of hepatocellular carcinoma. American Journal of Transplantation. 2015;15:2704.
  24. De Assuncao TM, et al. Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Laboratory Investigation. 2015;95:684.
  25. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Feb. 15, 2016.
  26. Brown AY. Allscripts EPSi. Mayo Clinic, Rochester, Minn. March 22, 2016.
  27. Cook AJ. Allscripts EPSi. Mayo Clinic, Rochester, Minn. May 2, 2014.
  28. Krowka MJ, et al. International Liver Transplant Society practice guidelines: Diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100:1440.
  29. Patel K, et al. FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus. World Journal of Gastroenterology. 2011;17:4581.
  30. Singh S, et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: A diagnostic accuracy systematic review and individual participant data pooled analysis. European Radiology. 2016;26:1431.
  31. Han L, et al. Extracorporeal liver support and liver transplant for patients with acute-on-chronic liver failure. Seminars in Liver Disease. 2016;36:153. Accessed June 29, 2016.
  32. Gallagher C. Transplant genomics enters collaboration with Mayo Clinic (news release). Mayo Clinic, Rochester, Minn. June 27, 2016.
  33. Heilman RL (expert opinion). Mayo Clinic, Phoenix/Scottsdale, Ariz. June 24, 2016.